These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 9113063)

  • 1. Mode of cytostatic action of mesoionic oxatriazole nitric oxide donors in proliferating human hematopoietic cells.
    Vilpo JA; Vilpo LM; Vuorinen P; Moilanen E; Metsä-Ketelä T
    Anticancer Drug Des; 1997 Mar; 12(2):75-89. PubMed ID: 9113063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives on vascular smooth muscle cell mitogenesis and proliferation in vitro.
    Lähteenmäki T; Sievi E; Vapaatalo H
    Br J Pharmacol; 1998 Sep; 125(2):402-8. PubMed ID: 9786515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential protective properties of a stable, slow-releasing nitric oxide donor, GEA 3175, in the lung.
    Laursen BE; Stankevicius E; Pilegaard H; Mulvany M; Simonsen U
    Cardiovasc Drug Rev; 2006; 24(3-4):247-60. PubMed ID: 17214601
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide as a regulator of prostacyclin synthesis in cultured rat heart endothelial cells.
    Sievi E; Lähteenmäki TA; Alanko J; Vuorinen P; Vapaatalo H
    Arzneimittelforschung; 1997 Oct; 47(10):1093-8. PubMed ID: 9368700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-donating properties of mesoionic 3-aryl substituted oxatriazole-5-imine derivatives.
    Kankaanranta H; Rydell E; Petersson AS; Holm P; Moilanen E; Corell T; Karup G; Vuorinen P; Pedersen SB; Wennmalm A; Metsä-Ketelä T
    Br J Pharmacol; 1996 Feb; 117(3):401-406. PubMed ID: 8821526
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-releasing oxatriazole derivatives inhibit human lymphocyte proliferation by a cyclic GMP-independent mechanism.
    Kosonen O; Kankaanranta H; Lähde M; Vuorinen P; Ylitalo P; Moilanen E
    J Pharmacol Exp Ther; 1998 Jul; 286(1):215-20. PubMed ID: 9655862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition by nitric oxide-releasing compounds of prostacyclin production in human endothelial cells.
    Kosonen O; Kankaanranta H; Malo-Ranta U; Ristimäki A; Moilanen E
    Br J Pharmacol; 1998 Sep; 125(2):247-54. PubMed ID: 9786495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 3-Aminothymidine inhibits growth of cultured human T-cell acute lymphoblastoid leukemia cells.
    Ashida N; Asano S; Kohda K
    Anticancer Res; 1994; 14(5A):2061-2. PubMed ID: 7847851
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of human lymphocyte proliferation by nitric oxide-releasing oxatriazole derivatives.
    Kosonen O; Kankaanranta H; Vuorinen P; Moilanen E
    Eur J Pharmacol; 1997 Oct; 337(1):55-61. PubMed ID: 9389381
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GEA 3162 decomposes to co-generate nitric oxide and superoxide and induces apoptosis in human neutrophils via a peroxynitrite-dependent mechanism.
    Taylor EL; Rossi AG; Shaw CA; Dal Rio FP; Haslett C; Megson IL
    Br J Pharmacol; 2004 Sep; 143(1):179-85. PubMed ID: 15289284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cytotoxicity of 2-aldo- and 2-ketopyridine-N(4)-substituted thiosemicarbazones and mode of action in human Tmolt4 cells.
    Hall IH; Barnes BJ; Rowell JE; Shaffer KA; Cho SE; West DX; Stark AM
    Pharmazie; 2001 Aug; 56(8):648-53. PubMed ID: 11534344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide-releasing compounds inhibit neutrophil adhesion to endothelial cells.
    Kosonen O; Kankaanranta H; Malo-Ranta U; Moilanen E
    Eur J Pharmacol; 1999 Oct; 382(2):111-7. PubMed ID: 10528145
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Presence of methylthioadenosine phosphorylase (MTAP) in hematopoietic stem/progenitor cells: its therapeutic implication for MTAP (-) malignancies.
    Yu J; Batova A; Shao L; Carrera CJ; Yu AL
    Clin Cancer Res; 1997 Mar; 3(3):433-8. PubMed ID: 9815702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between adenosine and the oxatriazole derivative GEA 3175 in platelets.
    Asplund Persson A; Zalavary S; Lindström E; Whiss PA; Bengtsson T; Grenegård M
    Eur J Pharmacol; 2005 Jul; 517(3):149-57. PubMed ID: 15963495
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of intracerebroventricular and intravenous administration of nitric oxide donors on blood pressure and heart rate in anaesthetized rats.
    Nurminen ML; Vapaatalo H
    Br J Pharmacol; 1996 Dec; 119(7):1422-6. PubMed ID: 8968551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide/nucleophile complexes inhibit the in vitro proliferation of A375 melanoma cells via nitric oxide release.
    Maragos CM; Wang JM; Hrabie JA; Oppenheim JJ; Keefer LK
    Cancer Res; 1993 Feb; 53(3):564-8. PubMed ID: 8425188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radical releasing properties of nitric oxide donors GEA 3162, SIN-1 and S-nitroso-N-acetylpenicillamine.
    Holm P; Kankaanranta H; Metsä-Ketelä T; Moilanen E
    Eur J Pharmacol; 1998 Apr; 346(1):97-102. PubMed ID: 9617758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mesoionic oxatriazole derivatives--a new group of NO-donors.
    Karup G; Preikschat H; Wilhelmsen ES; Pedersen SB; Marcinkiewicz E; Cieślik K; Gryglewski RJ
    Pol J Pharmacol; 1994; 46(6):541-52. PubMed ID: 7620516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Redifferentiation of human hepatoma cell induced by 6-(p-chlorophenyl)-3-[1-(p-chlorophenyl)-5-methyl-1 H-1,2,3-triazol-4-yl]-s-triazolo[3,4-b]-1,3,4-thiadiazole (TDZ).
    Zhang Q; Pan J; Zheng RL; Wang Q
    Pharmazie; 2005 May; 60(5):378-82. PubMed ID: 15918590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pioglitazone inhibits the growth of human leukemia cell lines and primary leukemia cells while sparing normal hematopoietic stem cells.
    Saiki M; Hatta Y; Yamazaki T; Itoh T; Enomoto Y; Takeuchi J; Sawada U; Aizawa S; Horie T
    Int J Oncol; 2006 Aug; 29(2):437-43. PubMed ID: 16820887
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.